These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 36420759)
1. Fenebrutinib and BTK inhibition: Unveiling a new target for the treatment of chronic spontaneous urticaria. Carvallo A; Sánchez-Fernández S; Morales-Palacios MP Allergy; 2023 Feb; 78(2):603-605. PubMed ID: 36420759 [No Abstract] [Full Text] [Related]
2. Fenebrutinib in H Metz M; Sussman G; Gagnon R; Staubach P; Tanus T; Yang WH; Lim JJ; Clarke HJ; Galanter J; Chinn LW; Chu T; Teterina A; Burgess T; Haddon DJ; Lu TT; Maurer M Nat Med; 2021 Nov; 27(11):1961-1969. PubMed ID: 34750553 [TBL] [Abstract][Full Text] [Related]
3. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria. Skander D; Allenova A; Maurer M; Kolkhir P Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030 [No Abstract] [Full Text] [Related]
4. Does synthetic pharmacotherapy still have a place in treating chronic spontaneous urticaria? Thiede RM; Fazel M; MacDonald KM; Abraham I Expert Opin Pharmacother; 2022 Oct; 23(14):1563-1567. PubMed ID: 36173375 [No Abstract] [Full Text] [Related]
5. Does hydroxychloroquine work for chronic spontaneous urticaria? Kaplan AP J Allergy Clin Immunol Pract; 2023 Jun; 11(6):1983. PubMed ID: 37295866 [No Abstract] [Full Text] [Related]
6. Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinib. Elamin G; Aljoundi A; Alahmdi MI; Abo-Dya NE; Soliman MES J Mol Model; 2022 Oct; 28(11):355. PubMed ID: 36222928 [TBL] [Abstract][Full Text] [Related]
7. Emerging treatments for chronic urticaria. Wedi B Expert Opin Investig Drugs; 2022 Mar; 31(3):281-290. PubMed ID: 35166638 [TBL] [Abstract][Full Text] [Related]
8. Selective IgE Deficiency Predicts Poor or No Response of Chronic Spontaneous Urticaria to Omalizumab. Picado C; Mascaró JJ; Vlagea A; Pascal M; Muñoz-Cano R; Bartra J J Investig Allergol Clin Immunol; 2022 Dec; 32(6):504-506. PubMed ID: 35225792 [No Abstract] [Full Text] [Related]
9. Effects of the immunoglobulin/histamine complex in chronic spontaneous urticaria focusing on remission induction. Kim HS; Noh G Allergy; 2022 Sep; 77(9):2846-2848. PubMed ID: 35587440 [No Abstract] [Full Text] [Related]
14. Concurrent use of omalizumab and dupilumab in a 47-year-old woman with chronic spontaneous urticaria and atopic dermatitis. Holm JG; Sørensen JA; Thomsen SF Int J Dermatol; 2022 May; 61(5):e173-e174. PubMed ID: 34813086 [No Abstract] [Full Text] [Related]